166 related articles for article (PubMed ID: 11827873)
1. Past glory and future promise: maximizing and improving understanding of atrophy patterns in the diagnosis of degenerative dementias.
Miller BL
AJNR Am J Neuroradiol; 2002 Jan; 23(1):33-4. PubMed ID: 11827873
[No Abstract] [Full Text] [Related]
2. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.
Hanyu H; Asano T; Sakurai H; Tanaka Y; Takasaki M; Abe K
AJNR Am J Neuroradiol; 2002 Jan; 23(1):27-32. PubMed ID: 11827872
[TBL] [Abstract][Full Text] [Related]
3. [Dementia: role of imaging].
Meder JF; Henry-Feugeas MC; Oppenheim C; Naggara O; Frédy D
J Radiol; 2003 Nov; 84(11 Pt 2):1819-28. PubMed ID: 14739838
[TBL] [Abstract][Full Text] [Related]
4. MR features of the substantia innominata and therapeutic implications in dementias.
Hanyu H; Shimizu S; Tanaka Y; Hirao K; Iwamoto T; Abe K
Neurobiol Aging; 2007 Apr; 28(4):548-54. PubMed ID: 16569466
[TBL] [Abstract][Full Text] [Related]
5. MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.
Sasaki M; Ehara S; Tamakawa Y; Takahashi S; Tohgi H; Sakai A; Mita T
AJNR Am J Neuroradiol; 1995; 16(10):2001-7. PubMed ID: 8585486
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.
Hsu YY; Du AT; Schuff N; Weiner MW
J Geriatr Psychiatry Neurol; 2001; 14(3):145-66. PubMed ID: 11563438
[TBL] [Abstract][Full Text] [Related]
7. Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects?
Moon WJ; Kim HJ; Roh HG; Han SH
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1308-13. PubMed ID: 18436612
[TBL] [Abstract][Full Text] [Related]
8. [Neuroimaging and functional assessment in dementia].
Terashi A; Kitamura S; Ujike T
No To Shinkei; 1990 May; 42(5):435-48. PubMed ID: 2144981
[No Abstract] [Full Text] [Related]
9. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images.
Davis PC; Mirra SS; Alazraki N
AJR Am J Roentgenol; 1994 Jun; 162(6):1267-78. PubMed ID: 8191980
[TBL] [Abstract][Full Text] [Related]
10. Where's the chicken?
Huckman MS
AJNR Am J Neuroradiol; 1995; 16(10):2008-9. PubMed ID: 8585487
[No Abstract] [Full Text] [Related]
11. [Diagnostic imaging of dementia].
Terashi A
Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1704-9. PubMed ID: 9410988
[No Abstract] [Full Text] [Related]
12. [Evaluation of the contribution of the importance of neuroimaging for the diagnostics of dementias--comparison to the psychological diagnostics].
Hentschel F; Kreis M; Damian M; Syren M; Krumm B
Rofo; 2003 Oct; 175(10):1335-43. PubMed ID: 14556101
[TBL] [Abstract][Full Text] [Related]
13. Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients.
Tanaka Y; Hanyu H; Sakurai H; Takasaki M; Abe K
Dement Geriatr Cogn Disord; 2003; 16(3):119-25. PubMed ID: 12826736
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Büla C; Démonet JF; Frisoni GB; Giannakopoulos P; Gold G; Von Gunten A
Rev Med Suisse; 2016 Apr; 12(515):771-2. PubMed ID: 27276718
[No Abstract] [Full Text] [Related]
15. Dementia--an update.
Jagust W
West J Med; 1995 Nov; 163(5):473-4. PubMed ID: 8533415
[No Abstract] [Full Text] [Related]
16. Substantia innominata: MR findings in Parkinson's disease.
Oikawa H; Sasaki M; Ehara S; Abe T
Neuroradiology; 2004 Oct; 46(10):817-21. PubMed ID: 15316699
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
18. Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease.
Jaswal G; Swardfager W; Gao FQ; Nestor SM; Ganda A; Cogo-Moreira H; Sahlas DJ; Stuss DT; Moody A; Black SE
Neurobiol Aging; 2018 Jun; 66():23-31. PubMed ID: 29505952
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
20. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
Liberini P
Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
